Your browser doesn't support javascript.
loading
Extracellular Vesicles as Biomarkers and Therapeutics for Inflammatory Eye Diseases.
Louie, Henry H; Mugisho, Odunayo O; Chamley, Lawrence W; Rupenthal, Ilva D.
Afiliación
  • Louie HH; Buchanan Ocular Therapeutics Unit, Department of Ophthalmology, New Zealand National Eye Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
  • Mugisho OO; Hub for Extracellular Vesicle Investigations, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
  • Chamley LW; Buchanan Ocular Therapeutics Unit, Department of Ophthalmology, New Zealand National Eye Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
  • Rupenthal ID; Hub for Extracellular Vesicle Investigations, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Mol Pharm ; 20(1): 23-40, 2023 01 02.
Article en En | MEDLINE | ID: mdl-36332193
ABSTRACT
Extracellular vesicles (EVs) are a group of cell-derived membrane vesicles of varying sizes that can be secreted by most cells. Depending on the type of cell they are derived from, EVs may contain a variety of cargo including proteins, lipids, miRNA, and DNA. Functionally, EVs play important roles in physiological and pathological processes through intercellular communication. While there has already been significant literature on the involvement of EVs in neurological and cardiovascular disease as well as cancer, recent evidence suggests that EVs may also play a role in mediating inflammatory eye diseases. This paper summarizes current advancements in ocular EV research as well as new ways by which EVs may be utilized as novel biomarkers of or therapeutics for inflammatory eye diseases.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: MicroARNs / Oftalmopatías / Vesículas Extracelulares / Neoplasias Límite: Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Asunto principal: MicroARNs / Oftalmopatías / Vesículas Extracelulares / Neoplasias Límite: Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Nueva Zelanda